What You Should Know:
– Teladoc Health (NYSE:TDOC), a leader in virtual healthcare, presented compelling new data at the American Diabetes Association’s 84th Scientific Sessions. The findings showcase the effectiveness of Teladoc Health’s AI-powered approach to managing type 2 diabetes.
– The study focused on the impact of personalized health nudges on patients identified as at-risk for uncontrolled diabetes through mobile devices
AI-Driven Nudges Lead to Improved Blood Sugar Control
Key takeaways of the study include:
- Early Identification of At-Risk Patients: Teladoc Health’s AI technology can identify patients at risk for uncontrolled diabetes over a year in advance.
- Personalized Interventions: Patients identified as at-risk receive targeted nudges, promoting self-monitoring of their condition.
- Increased Engagement, Improved Outcomes: Patients receiving nudges showed a 3x increase in program engagement and a significant 0.4 point reduction in A1c (a key indicator of blood sugar control).
Personalized Coaching Enhances Engagement
Another study examined how tailored communication can improve patient engagement with coaching services. Here’s what they found:
- Personalized Next-Best-Action Emails: Teladoc Health leverages predictive modeling to recommend the most appropriate next steps (coaching, educational materials, etc.) for each patient based on their individual health data and program usage.
- Increased Coaching Utilization: Patients receiving these personalized emails were 50% more likely to engage with a health coach compared to those receiving standard communication.
